La Jolla Pharmaceutical Company
USD6.19
-0.02 (-0.32%)
CEO
George Tidmarsh
IPO Date
1994-06-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.20
Prev. Close
$6.21
Day Low
$6.19
Day High
$6.22
Volume
0.96M
| -2.7 |
| 31 Dec 2019 | FY | 89.6% | -505.4% | 208.1% | -88.1% | -0.52 | 3.96 | -0.9 |
| 31 Dec 2018 | FY | 83.7% | -1983.6% | -555.3% | -97.6% | 0.00 | 5.95 | -1.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -130.2% | -96.0% | 0.00 | 5.07 | -5.9 |
| 31 Dec 2016 | FY | 100.0% | -12692.4% | -128.1% | -110.4% | 0.00 | 6.91 | -3.9 |
| 31 Dec 2015 | FY | 100.0% | -3965.2% | -33.7% | -32.4% | 0.00 | 26.46 | -10.1 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -44.0% | -42.2% | 0.00 | 24.16 | -9.2 |
| 31 Dec 2013 | FY | 0.0% | 0.0% | -234.4% | -205.0% | 0.00 | 7.96 | -0.2 |
| 31 Dec 2012 | FY | 0.0% | 0.0% | -240.7% | -225.6% | 0.00 | 15.88 | -0.2 |
| 13964.5 |
| 31 Dec 2021 | Q4 | 82.6% | 10.8% | -2.0% | 1.3% | -0.04 | 3.82 | 24.2 |
| 30 Sept 2021 | Q3 | 78.4% | -17.0% | 3.3% | -2.3% | -0.04 | 4.12 | -12.1 |
| 30 Jun 2021 | Q2 | 86.6% | 23.2% | -5.5% | 3.7% | -0.04 | 4.05 | 7.9 |
| 31 Mar 2021 | Q1 | 81.5% | 42.2% | -19.9% | 16.1% | -0.04 | 4.63 | 2.0 |
| 31 Dec 2020 | Q4 | 65.2% | -31.8% | 3.9% | -4.8% | -0.01 | 2.95 | -7.6 |
| 30 Sept 2020 | Q3 | 72.6% | -129.6% | 13.8% | -14.6% | -0.03 | 2.25 | -2.3 |
| 30 Jun 2020 | Q2 | 86.1% | -268.6% | 20.7% | -14.5% | -0.37 | 4.43 | -1.9 |
| 31 Mar 2020 | Q1 | 90.6% | -113.2% | 13.9% | -7.3% | -0.46 | 5.37 | -3.3 |